Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29 Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Abbvie Inc drug VIEKI…
New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED) Read Post »
Annual Drug Patent Expirations for CHANTIX Chantix is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from five suppliers. There are three…
The post New patent expiration for Pf Prism drug CHANTIX appeared first on DrugPatent…
Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. It is available from two suppliers. There are…
The post New patent expiration for Becton Dickinson drug CH…
New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP Read Post »
DILAUDID-HP (hydromorphone hydrochloride) Fresenius kabi usa Patent: 6,589,960 Expiration: Nov 9, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent E…
Drug Patent Expirations for the Week of November 8, 2020 Read Post »
Annual Drug Patent Expirations for DILAUDID Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It is available from three suppliers.…
The post New patent expiration for Rhodes Pharms drug DILAUDID appeare…
New patent expiration for Rhodes Pharms drug DILAUDID Read Post »
Annual Drug Patent Expirations for PALLADONE Palladone is a drug marketed by Purdue Pharma Lp and is included in one NDA. There is one patent protecting this drug. Drug patent…
The post New patent expiration for Purdue Pharma drug PALLADONE appeared fi…
New patent expiration for Purdue Pharma drug PALLADONE Read Post »
Annual Drug Patent Expirations for DILAUDID Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It is available from three suppliers.…
The post New patent expiration for Fresenius Kabi drug DILAUDID appear…
New patent expiration for Fresenius Kabi drug DILAUDID Read Post »
Annual Drug Patent Expirations for DILAUDID-HP Dilaudid-hp is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Fresenius Kabi drug DILAUDID-HP appea…
New patent expiration for Fresenius Kabi drug DILAUDID-HP Read Post »
Annual Drug Patent Expirations for AXUMIN Axumin is a drug marketed by Blue Earth and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Blue Earth drug AXUMIN appeared first on DrugPat…
New patent expiration for Blue Earth drug AXUMIN Read Post »
DILAUDID-HP (hydromorphone hydrochloride) Fresenius kabi usa Patent: 6,589,960 Expiration: Nov 9, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent E…
Drug Patent Expirations for the Week of November 8, 2020 Read Post »